Sign In
Buy COR
$263.64
-1.20 (-0.453%)
At Close: Jun 03, 2026
Here's Why You Should Add Cencora Stock to Your Portfolio Now
09:46am, Tuesday, 11'th Mar 2025
COR continues to gain traction from the robust U.S. Healthcare Solutions segment. However, stiff competition is a woe.
Why Is Cencora (COR) Up 3.1% Since Last Earnings Report?
12:36pm, Friday, 07'th Mar 2025
Cencora (COR) reported earnings 30 days ago. What's next for the stock?
Scoop Up These 3 GARP Stocks to Receive Handsome Returns
09:20am, Friday, 28'th Feb 2025
The GARP strategy helps investors gain exposure to stocks that have impressive prospects and are trading at a discount. SFM, COR and AXP are some stocks that hold promise.
3 Reasons Why Growth Investors Shouldn't Overlook Cencora (COR)
01:45pm, Thursday, 27'th Feb 2025
Cencora (COR) possesses solid growth attributes, which could help it handily outperform the market.
Cencora: Higher Potential Returns After Reduced Walgreens Stake
11:00am, Wednesday, 26'th Feb 2025
Cencora offers steady revenue growth from pharmaceutical distribution, benefiting from rising healthcare demand and an aging population. The company has a strong economic moat, low leverage, BBB+ cred
Why Cencora (COR) is a Top Growth Stock for the Long-Term
10:45am, Friday, 21'st Feb 2025
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Here's Why Cencora (COR) is a Strong Value Stock
10:41am, Thursday, 20'th Feb 2025
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
3 GARP Stocks That Investors Can Scoop Up for Maximum Returns
08:32am, Thursday, 13'th Feb 2025
Try the GARP strategy when seeking a profitable portfolio of stocks offering optimum value and growth investing. AXP, COR and TPX hold promise.
Walgreens Sells Another Stake In Distributor Cencora For $300 Million
09:18pm, Thursday, 06'th Feb 2025
Walgreens Boots Alliance has sold more shares of drug distributor Cencora for proceeds of about $300 million, “primarily for debt paydown and general corporate purposes,” the company said Thursday
Cencora Announces Common Share Repurchase From Walgreens Boots Alliance
08:37pm, Thursday, 06'th Feb 2025
CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--Cencora, Inc. (NYSE: COR) today announced that it has agreed to repurchase shares of its common stock from Walgreens Boots Alliance Holdings LLC in the amount of ap
DEERFIELD, Ill.--(BUSINESS WIRE)--Walgreens Boots Alliance, Inc. (Nasdaq: WBA) has agreed to the early settlement of certain prepaid variable share forward transactions it had previously entered into
COR Stock Gains on Q1 Earnings & Revenue Beat & Upbeat '25 Outlook
12:51pm, Wednesday, 05'th Feb 2025
COR's first-quarter fiscal 2025 results showcase a strong segmental performance. The company's sales and earnings guidance for fiscal 2025 looks encouraging.
Cencora (COR) Q1 2025 Earnings Call Transcript
11:40am, Wednesday, 05'th Feb 2025
Cencora Inc. (NYSE:COR ) Q1 2025 Earnings Conference Call February 5, 2025 8:30 AM ET Company Participants Robert Mauch - President, Chief Executive Officer James Cleary - Executive Vice President, Ch
Here's What Key Metrics Tell Us About Cencora (COR) Q1 Earnings
10:36am, Wednesday, 05'th Feb 2025
The headline numbers for Cencora (COR) give insight into how the company performed in the quarter ended December 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estima
Cencora (COR) Surpasses Q1 Earnings and Revenue Estimates
08:40am, Wednesday, 05'th Feb 2025
Cencora (COR) came out with quarterly earnings of $3.73 per share, beating the Zacks Consensus Estimate of $3.50 per share. This compares to earnings of $3.28 per share a year ago.
